Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
H Liu, CL Han, BW Tian, ZN Ding, YF Yang… - Expert Review of …, 2023 - Taylor & Francis
Background Tenofovir (TDF) and entecavir (ETV) are first-line treatments for patients with
chronic hepatitis B virus (HBV) infection. However, the effect of TDF versus ETV on the …
chronic hepatitis B virus (HBV) infection. However, the effect of TDF versus ETV on the …
Assessment of adherence to clinical guidelines in patients with chronic hepatitis B
WK Katwaroe, SM Brakenhoff, DPC van der Spek… - Viruses, 2022 - mdpi.com
Background and aims: Adherence to guidelines is associated with improved long-term
outcomes in patients with chronic hepatitis B (CHB). We aimed to study the degree of …
outcomes in patients with chronic hepatitis B (CHB). We aimed to study the degree of …
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open …
Background Phase 3 studies in patients with chronic hepatitis B have shown tenofovir
alafenamide to have non-inferior efficacy to tenofovir disoproxil fumarate, with improved …
alafenamide to have non-inferior efficacy to tenofovir disoproxil fumarate, with improved …
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate
LY Liang, TCF Yip, JCT Lai, ASM Lam… - Journal of Medical …, 2022 - Wiley Online Library
Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir for the treatment of chronic
hepatitis B (CHB) infection. We aimed to evaluate the impact of switching to TAF on alanine …
hepatitis B (CHB) infection. We aimed to evaluate the impact of switching to TAF on alanine …
Tenofovir is associated with higher risk of kidney function decline than entecavir in patients with chronic hepatitis B
Methods Patients with treatment-naive CHB who were prescribed either ETV or TDF
between January 2007 and January 2019 were eligible for this retrospective, longitudinal …
between January 2007 and January 2019 were eligible for this retrospective, longitudinal …
Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study
J Lee, JG Lee, S Hwang, KW Lee, JM Kim… - Hepatology …, 2022 - Springer
Background and aims Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) have been
recommended after liver transplantation to prevent recurrence of hepatitis B virus infection …
recommended after liver transplantation to prevent recurrence of hepatitis B virus infection …
Treatment of chronic hepatitis B virus with oral anti-viral therapy
M Buti, M Riveiro-Barciela, R Esteban - Clinics in Liver Disease, 2021 - liver.theclinics.com
Nucleoside analogues (NAs) are the drugs most commonly used in the treatment of chronic
hepatitis B (CHB). These agents mainly act by inhibiting viral replication, and they have a …
hepatitis B (CHB). These agents mainly act by inhibiting viral replication, and they have a …
tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue.
SW Lee, SU Kim - Alimentary Pharmacology & Therapeutics, 2020 - search.ebscohost.com
Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal
impairment—still an open Page 1 Aliment Pharmacol Ther. 2020;52:889–890 …
impairment—still an open Page 1 Aliment Pharmacol Ther. 2020;52:889–890 …
[PDF][PDF] Observation of Glomerular Filtration Change in Chronic Hepatitis B Patients Using Tenofovir Disoproxil Fumarate.
M Karslıoğlu - Van Tip Dergisi, 2024 - jag.journalagent.com
Introduction: This study was conducted to assess kidney function tests in outpatient
individuals with a diagnosis of chronic hepatitis B who were receiving treatment with …
individuals with a diagnosis of chronic hepatitis B who were receiving treatment with …
[PDF][PDF] Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B. Viruses 2022, 14, 2229
WK Katwaroe, SM Brakenhoff, DPC van der Spek… - 2022 - pure.eur.nl
Background and aims: Adherence to guidelines is associated with improved long-term
outcomes in patients with chronic hepatitis B (CHB). We aimed to study the degree of …
outcomes in patients with chronic hepatitis B (CHB). We aimed to study the degree of …